[go: up one dir, main page]

Patwekar, 2016 - Google Patents

Solubility and dissolution enhancement of poorly water-soluble Ketoprofen by microwave-assisted Bionanocomposites: in vitro and in vivo study

Patwekar, 2016

View PDF
Document ID
2757262139918048813
Author
Patwekar S
Publication year
Publication venue
Asian Journal of Pharmaceutics (AJP)

External Links

Snippet

Aim: Dissolution and diffusion through gastrointestinal membrane are the mechanisms by which drug get absorbed on oral route of administration. The major challenge in case of the majority of drugs is poor water solubility. Hence, the objective of the present study is to …
Continue reading at asiapharmaceutics.info (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30—Macromolecular compounds

Similar Documents

Publication Publication Date Title
Nagy et al. High speed electrospinning for scaled-up production of amorphous solid dispersion of itraconazole
Dhumal et al. Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability
de Freitas et al. Inclusion complex of methyl-β-cyclodextrin and olanzapine as potential drug delivery system for schizophrenia
Sayyad et al. Design and development of liquisolid compact of candesartan cilexetil to enhance dissolution
Aceves et al. Preparation and characterization of Furosemide-Eudragit controlled release systems
Machmudah et al. Formation of fine particles from curcumin/PVP by the supercritical antisolvent process with a coaxial nozzle
Corti et al. Physical–chemical characterization of binary systems of metformin hydrochloride with triacetyl-β-cyclodextrin
Sonali et al. Silymarin-solid dispersions: characterization and influence of preparation methods on dissolution
Javeer et al. Enhanced solubility and dissolution of simvastatin by HPMC-based solid dispersions prepared by hot melt extrusion and spray-drying method
Thurein et al. Physicochemical properties of β-cyclodextrin solutions and precipitates prepared from injectable vehicles
Emami et al. Characterizing eutectic mixtures of gliclazide with succinic acid prepared by electrospray deposition and liquid assisted grinding methods
Patre et al. Formulation & Evaluation Of Piroxicam Bionanocomposite For Enhancement of Bioavailability
Patwekar Solubility and dissolution enhancement of poorly water-soluble Ketoprofen by microwave-assisted Bionanocomposites: in vitro and in vivo study
Ali et al. Engineering of solidified glyburide nanocrystals for tablet formulation via loading of carriers: downstream processing, characterization, and bioavailability
Kim et al. Electrostatic spraying for fine-tuning particle dimensions to enhance oral bioavailability of poorly water-soluble drugs
Bhat Microwave-generated bionanocomposites for solubility enhancement of nifedipine
Wahab et al. Preparation and evaluation of solid dispersions of ibuprofen using glucosamine HCl as a carrier
Bhat Bionanocomposites: Technique towards enhancement of solubility, drug release and bioavailability
Nadh et al. Formulation and Optimization of Zolmitriptan Orodispersible Tablets.
Shah et al. Microspheres by spray drying: An approach to enhance solubility of Bicalutamide
Bhat Mahesh et al. Optimization bionanocomposites of fenofibrate for enhancement of solubility and dissolution using microwave induced diffusion technique
Huang et al. Micronization of gemfibrozil by reactive precipitation process
Sneha et al. Enhanced dissolution and solubility of Epalrestat with β-Cyclodextrin ternary complex using Arginine
Solaiman et al. Naproxen microparticulate systems prepared using in situ crystallisation and freeze-drying techniques
Sonawane et al. Preparation and characterization of microwave-assisted candesartan cilexetil solid dispersions